Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: A double-blind, randomized, sham-controlled trial

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 3, 2012, Pages 257-264

  Huang, Man Li ^a   Luo, Ben Yan ^a   Hu, Jian Bo ^a   Wang, Shan Shan ^a   Zhou, Wei Hua ^a   Wei, Ning ^a   Hu, Shao Hua ^a   Xu, Yi ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Executive function; Hamilton depression rating scale; major depression; Montgomery Asberg depression rating scale; repetitive transcranial magnetic stimulation

Indexed keywords

CITALOPRAM; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXECUTIVE FUNCTION; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROPSYCHOLOGICAL TEST; PREFRONTAL CORTEX; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SCORING SYSTEM; STIMULUS RESPONSE; TASK PERFORMANCE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; TREATMENT RESPONSE; WISCONSIN CARD SORTING TEST; ADOLESCENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; EARLY DIAGNOSIS; EARLY INTERVENTION; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; STATISTICS;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CITALOPRAM; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84863851907     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867411433216     Document Type: Article

References (30)

1. Anderson IM, Delvai NA, Ashim B, et al. Adjunctive fast repetitive transcranial magnetic stimulation in depression. British Journal of Psychiatry. 2007 ; 190: 533-534 (Pubitemid 46868840)
2. Bortolomasi M, Minelli A, Fuggetta G, et al. Long-lasting effects of high frequency repetitive transcranial magnetic stimulation in major depressed patients. Psychiatry Research. 2007 ; 150: 181-186 (Pubitemid 46386292)
3. Brunoni AR, Fregni F. Accelerating response to antidepressant treatment in depression: a review and clinical suggestions. Progress in Neuro-psychopharmacology and Biological Psychiatry. 2010 ; 34: 437-438
4. Murray CJL, Lopez AD The Global Burden of Disease. Cambridge, USA: Harvard University Press, pp ; 1996: 412-811.
5. Fabre I, Galinowski A, Oppenheim C, et al. Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial. International Journal of Geriatric Psychiatry. 2004 ; 19: 833-842 (Pubitemid 39242888)
6. Fitzgerald PB. Emerging use of brain stimulation treatments for psychiatric disorders. Australian and New Zealand Journal of Psychiatry. 2011 ; 45: 1-16
7. Fregni F, Marcolin MA, Myczkowski M, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. International Journal of Neuropsychopharmacology. 2006 ; 9: 641-654 (Pubitemid 46127397)
8. Garcia-Toro M, Salva J, Daumal J, et al. High (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression. Psychiatry Research. 2006 ; 146: 53-57 (Pubitemid 43269988)
9. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of General Psychiatry. 2010 ; 67: 507-516
10. George MS, Nahas Z, Molloy M, et al. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biological Psychiatry. 2000 ; 48: 962-970
11. Grunhaus L, Schreiber S, Dolberg OT, et al. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biological Psychiatry. 2003 ; 53: 324-331 (Pubitemid 36175546)
12. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960 ; 23: 56-62
13. Hausmann A, Pascual-Leone A, Kemmler G, et al. No deterioration of cognitive performance in an aggressive unilateral and bilateral antidepressant rTMS add-on trial. Journal of Clinical Psychiatry. 2004 ; 65: 772-782
14. Henkel V, Seemuller F, Obermeier M, et al. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. Journal of Affective Disorders. 2009 ; 115: 439-449
15. Herwig U, Fallgatter AJ, Hoppner J, et al. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. British Journal of Psychiatry. 2007 ; 191: 441-448 (Pubitemid 350069586)
16. Holtzheimer PE, Avery D, Schlaepfer TE. Antidepressant effects of repetitive transcranial magnetic stimulation. British Journal of Psychiatry. 2004 ; 184: 541-542 (Pubitemid 38725719)
17. Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009 ; 34: 522-534
18. Loo CK, Mitchell PB. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. Journal of Affective Disorders. 2005 ; 88: 255-267 (Pubitemid 41447523)
19. Martis B, Alam D, Dowd SM, et al. Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clinical Neurophysiology. 2003 ; 114: 1125-1132 (Pubitemid 36694769)
20. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex. 1976 ; 12: 313-324 (Pubitemid 8008480)
21. Quitkin FM, Rabkin JG, Ross D, et al. Duration of antidepressant drug treatment. What is an adequate trial?. Archives of General Psychiatry. 1984a ; 41: 238-245 (Pubitemid 14168077)
22. Quitkin FM, Rabkin JG, Ross D, et al. Identification of true drug response to antidepressants. Use of pattern analysis. Archives of General Psychiatry. 1984b ; 41: 782-786 (Pubitemid 14092257)
23. Reitan RM. Validity of trail-making test as an indicator of brain organic damage. Perceptual and Motor Skills. 1958 ; 8: 271-276
24. Rossini D, Magri L, Lucca A, et al. Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. Journal of Clinical Psychiatry. 2005 ; 66: 1569-1575 (Pubitemid 43068697)
25. Rumi DO, Gattaz WF, Rigonatti SP, et al. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biological Psychiatry. 2005 ; 57: 162-166 (Pubitemid 40094716)
26. Schulze-Rauschenbach SC, Harms U, Schlaepfer TE, et al. Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. British Journal of Psychiatry. 2005 ; 186: 410-416 (Pubitemid 40663424)
27. Stroop JR. Studies of interference in serial verbal reactions. Journal of Experimental Psychology. 1992 ; 121: 15-23
28. Szegedi A, Jansen WT, van Willigenburg AP, et al. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry. 2009 ; 70: 344-353
29. Uchida H, Nakajima S, Suzuki T, et al. Accelerating response to antidepressant treatment in depression: A review and clinical suggestions. Progress in Neuro-psychopharmacology and Biological Psychiatry. 2010 ; 34: 259-264
30. van Calker D, Zobel I, Dykierek P, et al. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy. Journal of Affective Disorders. 2009 ; 114: 243-253